Eun S. Yi

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Clinical characteristics and long-term treatment outcomes in childhood myelodysplastic neoplasm: a nationwide population-based study in Korea.

Clinical characteristics and long-term treatment outcomes in childhood myelodysplastic neoplasm: a nationwide population-based study in Korea.

Journal: BMC cancer

Published: February 02, 2026

Incidence and Characteristics of Psychiatric Disorders in Adolescent and Young Adult Patients with Malignant Brain Tumors.

Incidence and Characteristics of Psychiatric Disorders in Adolescent and Young Adult Patients with Malignant Brain Tumors.

Journal: Journal of adolescent and young adult oncology

Published: October 09, 2025

Second Allogeneic Hematopoietic Cell Transplantation Following Graft Failure in Children.

Second Allogeneic Hematopoietic Cell Transplantation Following Graft Failure in Children.

Journal: Journal of Korean medical science

Published: June 12, 2024

The Effect of Hematopoietic Stem Cell Transplantation on Treatment Outcome in Children with Acute Lymphoblastic Leukemia.

The Effect of Hematopoietic Stem Cell Transplantation on Treatment Outcome in Children with Acute Lymphoblastic Leukemia.

Journal: Cancer research and treatment

Published: February 14, 2024

Survival of Children with Acute Lymphoblastic Leukemia with Risk Group-Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period.

Survival of Children with Acute Lymphoblastic Leukemia with Risk Group-Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period.

Journal: Cancer research and treatment

Published: February 06, 2024

Factors Associated With Quality of Life Among Posttreatment Cancer Survivors in Korea: A Meta-analysis.

Factors Associated With Quality of Life Among Posttreatment Cancer Survivors in Korea: A Meta-analysis.

Journal: Cancer nursing

Published: July 31, 2023

Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group.

Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group.

Journal: Leukemia research

Published: February 06, 2023

Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.

Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.

Journal: Clinical immunology (Orlando, Fla.)

Published: November 30, 2022

Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group.

Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group.

Journal: Bone marrow transplantation

Published: April 24, 2022

Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants.

Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants.

Journal: Annals of hematology

Published: June 21, 2021

Methotrexate polyglutamate quantification for clinical application in patients with pediatric acute lymphoblastic leukemia in association with genetic polymorphisms.

Methotrexate polyglutamate quantification for clinical application in patients with pediatric acute lymphoblastic leukemia in association with genetic polymorphisms.

Journal: Journal of pharmaceutical and biomedical analysis

Published: February 02, 2021

DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.

DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.

Journal: PloS one

Published: September 04, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026